ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravir
​Natco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. ​"We have submitted phase-III clinical trial results of Molnupiravir to DCGI and we are awaiting for their marketing permission,”
Announcement as on 28 October 2021

Dr Reddy's, Natco Pharma launch generic cancer drug in Canada
Dr Reddy's Laboratories and Natco Pharma on Thursday said they have launched generic capsules used in the treatment of multiple myeloma and myelodysplastic syndrome patients in the Canadian market.
Announcement as on 02 September 2021

Natco Pharma share price falls 5% on setback in US patent litigation
Natco and partner Alvogen are reviewing the order and will evaluate all options to appeal the judgment, the pharma firm has said
Announcement as on 20 August 2021

Natco Pharma Q1 results: Net profit declines 39% to Rs 75 cr
Consolidated total income of the company stood at Rs 427.3 crore for the quarter under consideration. It was Rs 582.1 crore for the same period a year ago.
Announcement as on 12 August 2021

Biggest gainers & losers of the day: Paper, brokerage stocks fly high; Natco Pharma tanks 7%
Paper stocks and brokerage stocks have been on a roll today, with multiple counters hitting the buyer circuit. Multiple stocks fell after the stock exchanges sought clarification on them.
Announcement as on 07 July 2021

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 789.55
  • 12Day Average: 788.68
  • 20Day Average: 801.68
  • 50Day Average: 831.01
  • 100Day Average: 874.7
  • 150Day Average: 943.99
  • 200Day Average: 931.32

524816 Indicators & signals

Indicator MACD (12,26,9)

792.78, 806.12, -14.51
Indicator MACD is in negative zone

Indicator ADX (14)

20.75, 11.83, 18.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 782.50 780.00 to 801.15 -0.67% 0.73 times
29 Thu Oct 2026 787.75 786.00 to 799.15 -0.71% 0.66 times
28 Wed Oct 2026 793.35 779.95 to 801.85 -0.09% 2.83 times
27 Tue Oct 2026 794.05 784.65 to 798.00 0.5% 0.45 times
26 Mon Oct 2026 790.10 782.85 to 796.15 -0.27% 0.63 times
23 Fri Oct 2026 792.20 778.00 to 796.70 0.85% 1.25 times
22 Thu Oct 2026 785.50 774.00 to 789.00 0.08% 0.99 times
21 Wed Oct 2026 784.90 779.45 to 808.95 -1.98% 0.55 times
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 1.78 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.25 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.61 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 0.88 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top